Here's the Single Most Important Detail in Pfizer's Q3 Update

Pfizer (NYSE: PFE) hit a home run in the third quarter. The ball nearly went out of the park altogether.

The big drugmaker reported Q3 revenue of $24.1 billion, up 130% year over year. Adjusted earnings soared 133% to nearly $7.7 billion. Both top and bottom lines handily beat Wall Street estimates. 

Pfizer even raised its full-year 2021 guidance. It now expects revenue between $81 billion and $82 billion, a 94% year-over-year increase at the midpoint of the range. The company projects adjusted earnings per share will be between $4.13 and $4.18, up 84% at the midpoint.

Continue reading

Source Fool.com